161 related articles for article (PubMed ID: 23014266)
1. Medical treatment of acquired nystagmus.
Ehrhardt D; Eggenberger E
Curr Opin Ophthalmol; 2012 Nov; 23(6):510-6. PubMed ID: 23014266
[TBL] [Abstract][Full Text] [Related]
2. [Pharmacological treatment of nystagmus].
Pieh-Beisse C; Lagrèze WA
Ophthalmologe; 2011 Feb; 108(2):178-82. PubMed ID: 21253746
[TBL] [Abstract][Full Text] [Related]
3. Pharmacology of vertigo/nystagmus/oscillopsia.
Straube A
Curr Opin Neurol; 2005 Feb; 18(1):11-4. PubMed ID: 15655396
[TBL] [Abstract][Full Text] [Related]
4. Nystagmus: an update on treatment in adults.
Straube A
Expert Opin Pharmacother; 2005 Apr; 6(4):583-90. PubMed ID: 15934884
[TBL] [Abstract][Full Text] [Related]
5. [Pharmacotherapy of central oculomotor disorders].
Kalla R; Spiegel R; Wagner J; Rettinger N; Jahn K; Strupp M
Nervenarzt; 2008 Dec; 79(12):1377-8, 1380-2, 1384-5. PubMed ID: 18633586
[TBL] [Abstract][Full Text] [Related]
6. 4-aminopyridine restores vertical and horizontal neural integrator function in downbeat nystagmus.
Kalla R; Glasauer S; Büttner U; Brandt T; Strupp M
Brain; 2007 Sep; 130(Pt 9):2441-51. PubMed ID: 17664175
[TBL] [Abstract][Full Text] [Related]
7. Potassium channels, the cerebellum, and treatment for downbeat nystagmus.
Leigh RJ
Neurology; 2003 Jul; 61(2):158-9. PubMed ID: 12874391
[No Abstract] [Full Text] [Related]
8. 4-Aminopyridine suppresses positional nystagmus caused by cerebellar vermis lesion.
Kremmyda O; Zwergal A; la Fougère C; Brandt T; Jahn K; Strupp M
J Neurol; 2013 Jan; 260(1):321-3. PubMed ID: 23180177
[No Abstract] [Full Text] [Related]
9. 4-aminopyridine restores visual ocular motor function in upbeat nystagmus.
Glasauer S; Kalla R; Büttner U; Strupp M; Brandt T
J Neurol Neurosurg Psychiatry; 2005 Mar; 76(3):451-3. PubMed ID: 15716550
[TBL] [Abstract][Full Text] [Related]
10. 4-aminopyridine improves downbeat nystagmus, smooth pursuit, and VOR gain.
Kalla R; Glasauer S; Schautzer F; Lehnen N; Büttner U; Strupp M; Brandt T
Neurology; 2004 Apr; 62(7):1228-9. PubMed ID: 15079036
[No Abstract] [Full Text] [Related]
11. Clinical use of 4-aminopyridine in patients with downbeat nystagmus.
Domínguez-Durán E; Mármol-Szombathy I; Baños-Roldán Ú; Sánchez-Gómez S
Acta Otorrinolaringol Esp (Engl Ed); 2020; 71(1):40-44. PubMed ID: 31078225
[TBL] [Abstract][Full Text] [Related]
12. Periodic alternating nystagmus.
DiBartolomeo JR; Yee RD
Otolaryngol Head Neck Surg; 1988 Dec; 99(6):552-7. PubMed ID: 3148116
[TBL] [Abstract][Full Text] [Related]
13. Modelling drug modulation of nystagmus.
Glasauer S; Rössert C
Prog Brain Res; 2008; 171():527-34. PubMed ID: 18718349
[TBL] [Abstract][Full Text] [Related]
14. A randomized trial of 4-aminopyridine in EA2 and related familial episodic ataxias.
Hess E
Neurology; 2011 Nov; 77(22):1996-7; author reply 1997. PubMed ID: 22123782
[No Abstract] [Full Text] [Related]
15. Effect of 3,4-diaminopyridine on the postural control in patients with downbeat nystagmus.
Sprenger A; Zils E; Rambold H; Sander T; Helmchen C
Ann N Y Acad Sci; 2005 Apr; 1039():395-403. PubMed ID: 15826992
[TBL] [Abstract][Full Text] [Related]
16. Beneficial effects of 3,4-diaminopyridine on positioning downbeat nystagmus in a circumscribed uvulo-nodular lesion.
Helmchen C; Gottschalk S; Sander T; Trillenberg P; Rambold H; Sprenger A
J Neurol; 2007 Aug; 254(8):1126-8. PubMed ID: 17410325
[No Abstract] [Full Text] [Related]
17. Effect of 3,4-diaminopyridine on the gravity dependence of ocular drift in downbeat nystagmus.
Helmchen C; Sprenger A; Rambold H; Sander T; Kömpf D; Straumann D
Neurology; 2004 Aug; 63(4):752-3. PubMed ID: 15326263
[No Abstract] [Full Text] [Related]
18. Pharmacological advances in the treatment of neuro-otological and eye movement disorders.
Strupp M; Brandt T
Curr Opin Neurol; 2006 Feb; 19(1):33-40. PubMed ID: 16415675
[TBL] [Abstract][Full Text] [Related]
19. Effects of dalfampridine on attacks in patients with episodic ataxia type 2: an observational study.
Claassen J; Teufel J; Kalla R; Spiegel R; Strupp M
J Neurol; 2013 Feb; 260(2):668-9. PubMed ID: 23183922
[No Abstract] [Full Text] [Related]
20. Update on the pharmacotherapy of cerebellar and central vestibular disorders.
Kalla R; Teufel J; Feil K; Muth C; Strupp M
J Neurol; 2016 Apr; 263 Suppl 1():S24-9. PubMed ID: 27083881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]